Wurster-Hill D H, McIntyre O R
Virchows Arch B Cell Pathol. 1978 Nov 17;29(1-2):39-44. doi: 10.1007/BF02899334.
Polycythemia vera (PV) represents an apparent monoclonal stem cell proliferation with a frequent transition to full neoplastic behavior. Up to 26% of untreated PV patients can be expected to have some chromosome abnormalities in the marrow at the time of diagnosis, and 10--15% have an abnormal cell line or clone. Both structural and numerical aberrations occur. Aneuploidy is the most common type of chromosome abnormality, however, with hyperdiploid clones occurring more frequently than hypodiploid clones. Chromosomes 1, 8, 9 and 20 are involved in a non-random pattern, and aberrations of all the F group, or at least the No. 20 chromosome seem to be associated to some extent with diseases involving erythroid hyperplasia. Leukemia develops in a certain percentage of patients regardless of the type of treatment they have received, but the relationship, if any, between the chromosome abnormalities and the development of leukemia is still uncertain. The abnormal clones that occur in PV appear to be quite stable and there is no indication at this time that they correlate with a prognosis of leukemic transformation.
真性红细胞增多症(PV)表现为明显的单克隆干细胞增殖,且常转变为完全的肿瘤行为。预计高达26%未经治疗的PV患者在诊断时骨髓会出现一些染色体异常,10% - 15%有异常细胞系或克隆。结构和数量畸变均会发生。非整倍体是最常见的染色体异常类型,然而,超二倍体克隆比亚二倍体克隆更频繁出现。1号、8号、9号和20号染色体以非随机模式受累,所有F组染色体或至少20号染色体的畸变似乎在一定程度上与涉及红系增生的疾病相关。无论接受何种治疗,一定比例的患者会发生白血病,但染色体异常与白血病发生之间的关系(如果有的话)仍不确定。PV中出现的异常克隆似乎相当稳定,目前没有迹象表明它们与白血病转化的预后相关。